Walgreens Boots Alliance (NASDAQ:WBA) Releases FY 2024 Earnings Guidance

Walgreens Boots Alliance (NASDAQ:WBA) updated its FY 2024 earnings guidance on Thursday. The company provided earnings per share (EPS) guidance of 2.800-2.950 for the period, compared to the consensus estimate of 3.200. The company issued revenue guidance of -. Walgreens Boots Alliance also updated its FY24 guidance to $2.80-$2.95 EPS.

Walgreens Boots Alliance Price Performance

NASDAQ:WBA opened at $12.10 on Friday. The firm’s 50-day moving average price is $16.49 and its 200-day moving average price is $20.19. The company has a quick ratio of 0.32, a current ratio of 0.65 and a debt-to-equity ratio of 0.49. Walgreens Boots Alliance has a 1-year low of $11.68 and a 1-year high of $31.32.

Walgreens Boots Alliance (NASDAQ:WBA) last released its earnings results on Thursday, June 27th. The pharmacy operator reported $0.63 earnings per share for the quarter, missing analysts’ consensus estimates of $0.67 by ($0.04). The business had revenue of $36.40 billion during the quarter, compared to analysts’ expectations of $35.94 billion. Walgreens Boots Alliance had a positive return on equity of 12.63% and a negative net margin of 3.99%. The firm’s quarterly revenue was up 2.8% compared to the same quarter last year. During the same period in the prior year, the company earned $1.00 earnings per share. On average, sell-side analysts anticipate that Walgreens Boots Alliance will post 2.88 EPS for the current year.

Walgreens Boots Alliance Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, June 12th. Shareholders of record on Tuesday, May 21st were paid a dividend of $0.25 per share. The ex-dividend date was Monday, May 20th. This represents a $1.00 dividend on an annualized basis and a yield of 8.27%. Walgreens Boots Alliance’s dividend payout ratio is currently -14.84%.

Analyst Upgrades and Downgrades

A number of brokerages have recently issued reports on WBA. Evercore ISI dropped their price target on shares of Walgreens Boots Alliance from $17.00 to $10.00 and set an in-line rating on the stock in a report on Friday. SVB Leerink dropped their price target on shares of Walgreens Boots Alliance from $23.00 to $22.00 and set a market perform rating on the stock in a report on Monday, March 18th. Raymond James reaffirmed a market perform rating on shares of Walgreens Boots Alliance in a report on Tuesday, March 26th. Barclays dropped their price objective on shares of Walgreens Boots Alliance from $21.00 to $19.00 and set an underweight rating on the stock in a report on Monday, June 24th. Finally, Bank of America reissued an underperform rating and issued a $11.00 price objective (down previously from $22.00) on shares of Walgreens Boots Alliance in a report on Friday. Four research analysts have rated the stock with a sell rating, eleven have issued a hold rating and two have issued a buy rating to the company. Based on data from MarketBeat.com, the stock has an average rating of Hold and an average target price of $20.64.

Insider Buying and Selling

In other news, Director Inderpal S. Bhandari acquired 3,000 shares of the company’s stock in a transaction on Thursday, April 11th. The stock was bought at an average cost of $18.05 per share, with a total value of $54,150.00. Following the completion of the purchase, the director now directly owns 3,000 shares of the company’s stock, valued at $54,150. The purchase was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. In other news, Director Inderpal S. Bhandari acquired 3,000 shares of the company’s stock in a transaction on Thursday, April 11th. The stock was bought at an average cost of $18.05 per share, with a total value of $54,150.00. Following the completion of the purchase, the director now directly owns 3,000 shares of the company’s stock, valued at $54,150. The purchase was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CFO Manmohan Mahajan acquired 6,000 shares of the company’s stock in a transaction on Tuesday, April 2nd. The shares were purchased at an average cost of $19.38 per share, with a total value of $116,280.00. Following the completion of the purchase, the chief financial officer now directly owns 166,969 shares of the company’s stock, valued at $3,235,859.22. The disclosure for this purchase can be found here. 17.40% of the stock is currently owned by company insiders.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.